These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 24468852)
21. A comparison of the diagnostic accuracy of 18F-FDG PET and CT in the characterization of solitary pulmonary nodules. Fletcher JW; Kymes SM; Gould M; Alazraki N; Coleman RE; Lowe VJ; Marn C; Segall G; Thet LA; Lee K; J Nucl Med; 2008 Feb; 49(2):179-85. PubMed ID: 18199626 [TBL] [Abstract][Full Text] [Related]
22. Dual-time-point Huang YE; Huang YJ; Ko M; Hsu CC; Chen CF Ann Nucl Med; 2016 Nov; 30(9):652-658. PubMed ID: 27492555 [TBL] [Abstract][Full Text] [Related]
23. Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose avidity on positron emission tomography/computed tomography. Bar-Shalom R; Kagna O; Israel O; Guralnik L Cancer; 2008 Dec; 113(11):3213-21. PubMed ID: 18924145 [TBL] [Abstract][Full Text] [Related]
24. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics. Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193 [TBL] [Abstract][Full Text] [Related]
25. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5. Hashimoto Y; Tsujikawa T; Kondo C; Maki M; Momose M; Nagai A; Ohnuki T; Nishikawa T; Kusakabe K J Nucl Med; 2006 Mar; 47(3):426-31. PubMed ID: 16513611 [TBL] [Abstract][Full Text] [Related]
26. Shorter-time dual-phase FDG PET/CT in characterizing solid or ground-glass nodules based on surgical results. Chiu CF; Lin YY; Hsu WH; Chen CY; Yeh JJ; Kao CH Clin Imaging; 2012; 36(5):509-14. PubMed ID: 22920354 [TBL] [Abstract][Full Text] [Related]
27. The role of ¹⁸F-FDG PET or ¹⁸F-FDG-PET/CT in the evaluation of solitary pulmonary nodules. Li W; Pang H; Liu Q; Zhou J Eur J Radiol; 2015 Oct; 84(10):2032-7. PubMed ID: 26094866 [TBL] [Abstract][Full Text] [Related]
28. Contribution of nonattenuation-corrected images on FDG-PET/CT in the assessment of solitary pulmonary nodules. Şahin E; Kara A; Elboğa U Radiol Med; 2016 Dec; 121(12):944-949. PubMed ID: 27567614 [TBL] [Abstract][Full Text] [Related]
29. Usefulness of dual-phase 18F-FDG PET/CT for diagnosing small pancreatic tumors. Kawada N; Uehara H; Hosoki T; Takami M; Shiroeda H; Arisawa T; Tomita Y Pancreas; 2015 May; 44(4):655-9. PubMed ID: 25815646 [TBL] [Abstract][Full Text] [Related]
30. The role of dual time point FDG PET imaging in the evaluation of solitary pulmonary nodules with an initial standard uptake value less than 2.5. Macdonald K; Searle J; Lyburn I Clin Radiol; 2011 Mar; 66(3):244-50. PubMed ID: 21295203 [TBL] [Abstract][Full Text] [Related]
31. Dual-phase 18F-FDG PET in the diagnosis of pulmonary nodules with an initial standard uptake value less than 2.5. Chen CJ; Lee BF; Yao WJ; Cheng L; Wu PS; Chu CL; Chiu NT AJR Am J Roentgenol; 2008 Aug; 191(2):475-9. PubMed ID: 18647920 [TBL] [Abstract][Full Text] [Related]
32. Differential diagnosis between (18)F-FDG-avid metastatic lymph nodes in non-small cell lung cancer and benign nodes on dual-time point PET/CT scan. Suga K; Kawakami Y; Hiyama A; Sugi K; Okabe K; Matsumoto T; Ueda K; Tanaka N; Matsunaga N Ann Nucl Med; 2009 Aug; 23(6):523-31. PubMed ID: 19444550 [TBL] [Abstract][Full Text] [Related]
33. The role of ¹⁸F-FDG uptake features in the differential diagnosis of solitary pulmonary lesions with PET/CT. Zhao M; Chang B; Wei Z; Yu H; Tian R; Yuan L; Jin H World J Surg Oncol; 2015 Sep; 13():271. PubMed ID: 26369407 [TBL] [Abstract][Full Text] [Related]
34. Predictive value of dual-time Pahk K; Chung JH; Kim S; Lee SH Tumori; 2018 Jun; 104(3):207-212. PubMed ID: 29714664 [TBL] [Abstract][Full Text] [Related]
35. Characterization of pulmonary lesions with low F-18 FDG uptake using double phase F-18 FDG PET/CT: comparison of visual and quantitative analyses. Kim IJ; Kim SJ; Kim YS; Lee TH; Jeong YJ Neoplasma; 2009; 56(1):33-9. PubMed ID: 19152243 [TBL] [Abstract][Full Text] [Related]
37. Performance of FDG-PET/CT in solitary pulmonary nodule based on pre-test likelihood of malignancy: results from the ITALIAN retrospective multicenter trial. Evangelista L; Cuocolo A; Pace L; Mansi L; Del Vecchio S; Miletto P; Sanfilippo S; Pellegrino S; Guerra L; Pepe G; Peluso G; Salvatore M; Galicchio R; Zuffante M; Annunziata S; Farsad M; Chiaravalloti A; Spadafora M Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1898-1907. PubMed ID: 29736699 [TBL] [Abstract][Full Text] [Related]
38. Is there a common SUV threshold in oncological FDG PET/CT, at least for some common indications? A retrospective study. Nguyen NC; Kaushik A; Wolverson MK; Osman MM Acta Oncol; 2011 Jun; 50(5):670-7. PubMed ID: 21247262 [TBL] [Abstract][Full Text] [Related]
39. Dynamic contrast-enhanced MRI versus Feng F; Qiang F; Shen A; Shi D; Fu A; Li H; Zhang M; Xia G; Cao P Chin J Cancer Res; 2018 Feb; 30(1):21-30. PubMed ID: 29545716 [TBL] [Abstract][Full Text] [Related]
40. 18F-FDG PET/CT qualitative and quantitative evaluation in neurofibromatosis type 1 patients for detection of malignant transformation: comparison of early to delayed imaging with and without liver activity normalization. Chirindel A; Chaudhry M; Blakeley JO; Wahl R J Nucl Med; 2015 Mar; 56(3):379-85. PubMed ID: 25655626 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]